This website uses only strictly necessary cookies to ensure it functions properly and delivers the best experience. These essential cookies are automatically enabled and cannot be disabled. We do not use cookies for tracking, advertising, or any other purposes. By continuing to use our site, you agree to the use of these essential cookies.
Home ยป NS5A resistance leading to failure of 24-week...
NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient
Printer-friendly version